The Abu-Remaileh Lab published an atlas of proteins, found in lysosomes across different brain cell types, to advance research on neurodegenerative diseases.

Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), joins the global ...

A new study describes a technique that rejuvenates aging blood-forming stem cells and could help reduce the risk of age-related blood disorders.

Explore how tuberculosis bacteria survive within human cells, revealing potential paths for new treatments against this ...

Structural nanomedicine — what helped give us the COVID vaccine — may now be the key to a potent blood cancer treatment that’s had remarkable early results.

By Tarun Sai Lomte Researchers report that declining PPP2R5C levels in blood may signal early Alzheimer’s pathology, offering new insight into tau regulation and future diagnostic strategies Study: ...

On Rare Disease Day, February 28, the spotlight turns to conditions that are individually rare but together affect many families. At Bielefeld ...

A protein’s life is anything but simple. Discover how transcription, translation, folding, modification, and degradation work together to preserve proteome integrity.

Researchers in Japan have identified a striking new way immune cells strip DNA out of dying neighbors, a process they call ...

This discovery is important because it suggests a safer way to treat Alzheimer’s disease. Instead of trying to reduce essential brain chemicals, future treatments could focus on enhancing the brain’s ...

Researchers have identified a lipid-driven biophysical mechanism that allows tuberculosis-causing mycobacteria to survive inside human immune cells, a discovery that could inform novel ...

On World Rare Disease Day, we take a look at Pompe disease - a rare genetic disorder caused by a deficiency of the GAA enzyme, leading to glycogen buildup in muscles. It results in progressive muscle ...